Surpassing conventional therapies: The role of biologic therapy

被引:4
作者
Baldassano, RN [1 ]
机构
[1] Childrens Hosp Philadelphia, Ctr Pediat Inflammatory Bowel Dis, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA
关键词
D O I
10.1097/00005176-200109001-00004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S19 / S26
页数:8
相关论文
共 27 条
  • [1] Baldassano R, 1999, GASTROENTEROLOGY, V116, pA665
  • [2] TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION
    BRAEGGER, CP
    NICHOLLS, S
    MURCH, SH
    STEPHENS, S
    MACDONALD, TT
    [J]. LANCET, 1992, 339 (8785) : 89 - 91
  • [3] Etanercept (TNF receptor fusion protein, Enbrel®) is effective and well tolerated in active refractory Crohn's disease:: Results of a single center pilot trial.
    D'Haens, G
    Swijsen, C
    Noman, M
    Lemmens, L
    Geboes, K
    Rutgeerts, P
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A656 - A656
  • [4] Interleukin-11: Review of molecular, cell biology, and clinical use
    Du, XX
    Williams, DA
    [J]. BLOOD, 1997, 89 (11) : 3897 - 3908
  • [5] A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease.
    Feagan, BG
    Sandborn, WJ
    Baker, JP
    Cominelli, F
    Sutherland, LR
    Elson, CD
    Salzberg, B
    Archambault, A
    Bernstein, CN
    Lichtenstein, GR
    Heath, PK
    Hanauer, SB
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A655 - A655
  • [6] Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
    Fedorak, RN
    Gangl, A
    Elson, CO
    Rutgeerts, P
    Schreiber, S
    Wild, G
    Hanauer, SB
    Kilian, A
    Cohard, M
    LeBeaut, A
    Feagan, B
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1473 - 1482
  • [7] Use of infliximab in the treatment of Crohn's disease in children and adolescents
    Hyams, JS
    Markowitz, J
    Wyllie, R
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (02) : 192 - 196
  • [8] CONSTRUCTION AND INITIAL CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTI-TNF ANTIBODY
    KNIGHT, DM
    TRINH, H
    LE, JM
    SIEGEL, S
    SHEALY, D
    MCDONOUGH, M
    SCALLON, B
    MOORE, MA
    VILCEK, J
    DADDONA, P
    GHRAYEB, J
    [J]. MOLECULAR IMMUNOLOGY, 1993, 30 (16) : 1443 - 1453
  • [9] Message therapy: Gene therapy that targets mRNA sequence and stability
    Kozarsky, KF
    Couture, LA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : 790 - 794
  • [10] Kugathasan S, 2000, AM J GASTROENTEROL, V95, P3189